Haemonetics Corporation: shareholders and insiders

HAENYSEHealthcare · Surgical & Medical Instruments & Apparatus

Price

$122.86

November 18, 2026Market cap $5.6B

What Ploutos Investor adds for Haemonetics

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Nov 13, 2026, from their own Form 4 filings.

12 Form 4s

Bought on the market

–

nobody

Sold on the market

$101.1K

1 person

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $101.1K by 1 person

  • 2025: no buys, no sales
  • 2026: no buys, sold $101.1K by 1 person
  • Nov 11, 2026Farris Maryanne MaunsellVP, Chief Accounting Officer
    Kind
  • Nov 11, 2026Farris Maryanne MaunsellVP, Chief Accounting Officer
    Kind
  • Nov 11, 2026Farris Maryanne MaunsellVP, Chief Accounting Officer
    Kind
  • Nov 11, 2026Farris Maryanne MaunsellVP, Chief Accounting Officer
    Kind
  • Nov 11, 2026Farris Maryanne MaunsellVP, Chief Accounting Officer
    Kind
  • Oct 30, 2026Roy GalvinEVP, Chief Commercial Officer
    Kind
  • Jul 24, 2026Martin D MadausDirector
    Kind
  • Jul 24, 2026Ellen M ZaneDirector
    Kind
  • Jul 24, 2026Claire PomeroyDirector
    Kind
  • Jul 24, 2026Mark W KrollDirector
    Kind
  • Jul 24, 2026Lloyd Emerson JohnsonDirector
    Kind
  • Jul 24, 2026Michael J CoyleDirector
    Kind
  • Jul 24, 2026Diane M BryantDirector
    Kind
  • Jul 24, 2026Robert E AbernathyDirector
    Kind
  • Jun 5, 2026Farris Maryanne MaunsellVP, Chief Accounting Officer
    Kind
  • Jun 5, 2026Laurie A. MillerSVP, Human Resources
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by HAE's officers and directors from 2005 up to November 18, 2025, 21 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%Aug 12, 2026 Latest filing
  • Vanguard Portfolio Management
    Share of class5.59%
  • Vanguard Capital Management
    Share of class5.26%
Fell to 5% or less (6)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • AQR Capital Management, LLC4.99%Aug 12, 202613G/A
  • North Peak Capital Management, LLC0.00%May 13, 202613G/A
  • The Vanguard Group0.00%Mar 27, 202613G/A
  • Wellington Management Group LLP4.60%Aug 12, 202513G/A
  • T. Rowe Price Investment Management, Inc.4.40%May 14, 202513G/A
  • Capital Research Global Investors3.10%Apr 4, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Point72 (Cohen)
    In the quarter+718%
  • Citadel Advisors (Griffin)
    In the quarter+10%
  • AQR Capital
    In the quarter-20%
  • Millennium Mgmt (Englander)
    In the quarter+12%
  • Bridgewater (Dalio)
    In the quarter+23%
  • Renaissance Technologies
    In the quarter+11%
  • D.E. Shaw
    In the quarter+73%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 7.54% of its shares outstanding were held short, +12.8% since the report before.

Shares held short
3.43M
7.54%
Since the report before3.04M on Sep 30, 2026
+12.8%
3.9
881.3K
More days to cover thanof 4,578 US-listed companies with enough volume
47%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 1.68M
  • Nov 15, 2023: Shares held short 1.80M
  • Nov 30, 2023: Shares held short 1.69M
  • Dec 15, 2023: Shares held short 1.67M
  • Dec 29, 2023: Shares held short 1.82M
  • Jan 12, 2024: Shares held short 1.70M
  • Jan 31, 2024: Shares held short 1.67M
  • Feb 15, 2024: Shares held short 1.84M
  • Feb 29, 2024: Shares held short 1.96M
  • Mar 15, 2024: Shares held short 2.18M
  • Mar 28, 2024: Shares held short 2.04M
  • Apr 15, 2024: Shares held short 2.24M
  • Apr 30, 2024: Shares held short 2.62M
  • May 15, 2024: Shares held short 2.50M
  • May 31, 2024: Shares held short 3.26M
  • Jun 14, 2024: Shares held short 3.90M
  • Jun 28, 2024: Shares held short 4.22M
  • Jul 15, 2024: Shares held short 4.67M
  • Jul 31, 2024: Shares held short 4.80M
  • Aug 15, 2024: Shares held short 5.05M
  • Aug 30, 2024: Shares held short 6.09M
  • Sep 13, 2024: Shares held short 5.40M
  • Sep 30, 2024: Shares held short 5.42M
  • Oct 15, 2024: Shares held short 5.26M
  • Oct 31, 2024: Shares held short 5.16M
  • Nov 15, 2024: Shares held short 4.58M
  • Nov 29, 2024: Shares held short 4.57M
  • Dec 13, 2024: Shares held short 4.91M
  • Dec 31, 2024: Shares held short 5.23M
  • Jan 15, 2025: Shares held short 4.96M
  • Jan 31, 2025: Shares held short 5.24M
  • Feb 14, 2025: Shares held short 6.83M
  • Feb 28, 2025: Shares held short 6.47M
  • Mar 14, 2025: Shares held short 6.03M
  • Mar 31, 2025: Shares held short 4.53M
  • Apr 15, 2025: Shares held short 4.43M
  • Apr 30, 2025: Shares held short 4.35M
  • May 15, 2025: Shares held short 4.08M
  • May 30, 2025: Shares held short 4.12M
  • Jun 13, 2025: Shares held short 4.06M
  • Jun 30, 2025: Shares held short 3.66M
  • Jul 15, 2025: Shares held short 3.50M
  • Jul 31, 2025: Shares held short 3.08M
  • Aug 15, 2025: Shares held short 4.37M
  • Aug 29, 2025: Shares held short 3.67M
  • Sep 15, 2025: Shares held short 3.39M
  • Sep 30, 2025: Shares held short 3.13M
  • Oct 15, 2025: Shares held short 3.34M
  • Oct 31, 2025: Shares held short 3.12M
  • Nov 14, 2025: Shares held short 2.99M
  • Nov 28, 2025: Shares held short 3.62M
  • Dec 15, 2025: Shares held short 3.39M
  • Dec 31, 2025: Shares held short 3.49M
  • Jan 15, 2026: Shares held short 3.08M
  • Jan 30, 2026: Shares held short 2.41M
  • Feb 13, 2026: Shares held short 2.54M
  • Feb 27, 2026: Shares held short 2.71M
  • Mar 13, 2026: Shares held short 1.90M
  • Mar 31, 2026: Shares held short 2.07M
  • Apr 15, 2026: Shares held short 2.00M
  • Apr 30, 2026: Shares held short 1.98M
  • May 15, 2026: Shares held short 2.58M
  • May 29, 2026: Shares held short 2.96M
  • Jun 15, 2026: Shares held short 3.01M
  • Jun 30, 2026: Shares held short 2.91M
  • Jul 15, 2026: Shares held short 2.70M
  • Jul 31, 2026: Shares held short 2.92M
  • Aug 14, 2026: Shares held short 2.76M
  • Aug 31, 2026: Shares held short 2.86M
  • Sep 15, 2026: Shares held short 3.42M
  • Sep 30, 2026: Shares held short 3.04M
  • Oct 15, 2026: Shares held short 3.43M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading54.6% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 54.6% of the shares in the reported trades were short sales, against 51.8% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
54.6%
The 14 beforeOct 12, 2026 – Oct 29, 2026
51.8%
Change
+2.8 pts
Short sales a dayon average, of 271.8K shares
148.4K
More than atof 3,656 US-listed companies, same days
66%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 52.9%
  • Oct 13, 2026: Short sales 59.7%
  • Oct 14, 2026: Short sales 55.5%
  • Oct 15, 2026: Short sales 36%
  • Oct 16, 2026: Short sales 37.7%
  • Oct 19, 2026: Short sales 50%
  • Oct 20, 2026: Short sales 39.5%
  • Oct 21, 2026: Short sales 64%
  • Oct 22, 2026: Short sales 50.1%
  • Oct 23, 2026: Short sales 32.1%
  • Oct 26, 2026: Short sales 45.9%
  • Oct 27, 2026: Short sales 75%
  • Oct 28, 2026: Short sales 56.1%
  • Oct 29, 2026: Short sales 42.1%
  • Oct 30, 2026: Short sales 55.9%
  • Nov 2, 2026: Short sales 49.5%
  • Nov 3, 2026: Short sales 42.1%
  • Nov 4, 2026: Short sales 50.7%
  • Nov 5, 2026: Short sales 61.6%
  • Nov 6, 2026: Short sales 54.8%
  • Nov 9, 2026: Short sales 53.4%
  • Nov 10, 2026: Short sales 60.2%
  • Nov 11, 2026: Short sales 51.6%
  • Nov 12, 2026: Short sales 52.6%
  • Nov 13, 2026: Short sales 60.8%
  • Nov 16, 2026: Short sales 57.6%
  • Nov 17, 2026: Short sales 53.3%
  • Nov 18, 2026: Short sales 56.9%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

324.5K Insiders' shares0.71% Of the company
  • Laurie A. MillerSVP, Human Resources
    Directly41.0K
  • Roy GalvinEVP, Chief Commercial Officer
    Directly39.8K
  • Michelle L BasilEVP and General Counsel
    Directly35.4K
  • Robert E AbernathyDirector
    Directly27.5K
  • Mark W KrollDirector
    Directly27.3K
  • Ellen M ZaneDirector
    Directly21.9K
  • Anila LingamneniEVP, Chief Technology Officer
    Directly21.3K
  • Josep LlorensEVP, Global Manufacturing
    Directly21.3K
  • Claire PomeroyDirector
    Directly19.4K
  • Stewart W StrongPresident, Global Hospital
    Directly18.2K
  • Michael J CoyleDirector
    Directly17.9K
  • Lloyd Emerson JohnsonDirector
    Directly15.5K
  • Diane M BryantDirector
    Directly9,664
  • Farris Maryanne MaunsellVP, Chief Accounting Officer
    Directly5,828
  • Martin D MadausDirector
    Directly2,538

A lower bound: it counts only the 15 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

27 ETFs holding it0.20% The largest weight (IWO)
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.20%
  • FNDASchwab Fundamental U.S. Small Company ETF
    Weight in the fund0.17%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.16%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.11%
  • IJKiShares S&P Mid-Cap 400 Growth ETF
    Weight in the fund0.11%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.10%
  • SPMDState Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF
    Weight in the fund0.10%
  • IJHiShares Core S&P Mid-Cap ETF
    Weight in the fund0.10%
  • MDYState Street SPDR S&P MidCap 400SM ETF Trust
    Weight in the fund0.10%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.08%

27 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

329 Managers, Q2 2026$3.7B Value of their positions
  • Q3 2025: Managers 302
  • Q4 2025: Managers 330
  • Q1 2026: Managers 326
  • Q2 2026: Managers 329

Institutional investors by quarter

The fund managers holding HAE, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 329 managers held 49.65M shares, worth $3.7B. During the quarter 55 opened a position, 52 closed one, 105 added and 118 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+5.1%
  • Neuberger Berman Group
    In the quarter+17%
  • Vanguard Portfolio Management
    In the quarter-0.5%
  • AQR Capital
    In the quarter-32%
  • Ariel Investments
    In the quarter
  • Vanguard Capital Management
    In the quarter-1.5%
  • State Street
    In the quarter+2.6%
  • Dimensional Fund Advisors
    In the quarter+20%
  • Citadel Advisors (Griffin)
    In the quarter+485%
  • Geode Capital Management
    In the quarter+5.6%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Haemonetics's filings show?

Who buys and sells is one part of Haemonetics's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about HAE's shareholders

Didn't find what you were looking for?

Ask us
Have HAE's insiders bought or sold?

From Jun 8, 2026 to Nov 13, 2026 Haemonetics's insiders bought 0 and sold $101.1K of shares on the market. 0% of the sales were under set 10b5-1 plans.

Which well-known managers hold HAE?

7 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $190M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.